Literature DB >> 6407676

Effect of daily oral omeprazole on 24 hour intragastric acidity.

R P Walt, M D Gomes, E C Wood, L H Logan, R E Pounder.   

Abstract

Twenty four hour intragastric acidity was measured in nine patients with duodenal ulcer before and after one week of treatment with oral omeprazole 30 mg daily, a drug that inhibits gastric secretion by inhibition of parietal cell H+K+ adenosinetriphosphatase (ATPase). Omeprazole virtually eliminated intragastric acidity in all patients: the median 24 hour intragastric pH rose from 1.4 to 5.3 and the mean hourly hydrogen ion activity fell from 38.50 to 1.95 mmol(mEq)/1 (p less than 0.001). This inhibition of 24 hour intragastric acidity is more profound than that previously reported with either cimetidine 1 g daily or ranitidine 300 mg daily.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6407676      PMCID: PMC1548155          DOI: 10.1136/bmj.287.6384.12

Source DB:  PubMed          Journal:  Br Med J (Clin Res Ed)        ISSN: 0267-0623


  15 in total

1.  A nonelectrogenic H+ pump in plasma membranes of hog stomach.

Authors:  G Sachs; H H Chang; E Rabon; R Schackman; M Lewin; G Saccomani
Journal:  J Biol Chem       Date:  1976-12-10       Impact factor: 5.157

2.  Effect of cimetidine on 24-hour intragastric acidity in normal subjects.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1976-02       Impact factor: 23.059

Review 3.  Gastric adenosine triphosphatases: a review of their possible role in HCl secretion.

Authors:  J G Forte; H C Lee
Journal:  Gastroenterology       Date:  1977-10       Impact factor: 22.682

Review 4.  New histamine H2-receptor antagonists.

Authors:  S Domschke; W Domschke
Journal:  Hepatogastroenterology       Date:  1980-06

5.  Reduction of twenty-four-hour gastric acidity with combination drug therapy in patients with duodenal ulcer.

Authors:  W L Peterson; C Barnett; M Feldman; C T Richardson
Journal:  Gastroenterology       Date:  1979-11       Impact factor: 22.682

6.  24-hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer during oral administration of cimetidine and atropine.

Authors:  R E Pounder; R H Hunt; S H Vincent; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1977-02       Impact factor: 23.059

7.  24-hour control of intragastric acidity by cimetidine in duodenal-ulcer patients.

Authors:  R E Pounder; J G Williams; G J Milton-Thompson; J J Misiewicz
Journal:  Lancet       Date:  1975-11-29       Impact factor: 79.321

8.  Model of medical treatment for duodenal ulcer.

Authors:  R E Pounder
Journal:  Lancet       Date:  1981-01-03       Impact factor: 79.321

9.  Comparison of the effects of ranitidine, cimetidine and placebo on the 24 hour intragastric acidity and nocturnal acid secretion in patients with duodenal ulcer.

Authors:  R P Walt; P J Male; J Rawlings; R H Hunt; G J Milton-Thompson; J J Misiewicz
Journal:  Gut       Date:  1981-01       Impact factor: 23.059

10.  Characterization of gastric mucosal membranes. X. Immunological studies of gastric (H+ + K+)-ATPase.

Authors:  G Saccomani; H F Helander; S Crago; H H Chang; D W Dailey; G Sachs
Journal:  J Cell Biol       Date:  1979-11       Impact factor: 10.539

View more
  52 in total

1.  Comparison of omeprazole and ranitidine for stress ulcer prophylaxis.

Authors:  M J Levy; C B Seelig; N J Robinson; J E Ranney
Journal:  Dig Dis Sci       Date:  1997-06       Impact factor: 3.199

2.  Optimal dose of oral omeprazole for maximal 24 hour decrease of intragastric acidity.

Authors:  B K Sharma; R P Walt; R E Pounder; M D Gomes; E C Wood; L H Logan
Journal:  Gut       Date:  1984-09       Impact factor: 23.059

3.  Oral pharmacokinetics of omeprazole.

Authors:  C W Howden; P A Meredith; J A Forrest; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

4.  Effect of cimetidine and omeprazole on aspirin- and taurocholate-induced gastric mucosal damage in the rat.

Authors:  R J Utley; A S Salim; D C Carter
Journal:  Gut       Date:  1985-08       Impact factor: 23.059

Review 5.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

6.  Antisecretory effect and oral pharmacokinetics of omeprazole in patients with chronic renal failure.

Authors:  C W Howden; C D Payton; P A Meredith; D M Hughes; A I Macdougall; J L Reid; J A Forrest
Journal:  Eur J Clin Pharmacol       Date:  1985       Impact factor: 2.953

7.  Omeprazole inhibits nocturnal and pentagastrin-stimulated gastric secretion in man.

Authors:  J A Wilson; E J Boyd; K G Wormsley
Journal:  Dig Dis Sci       Date:  1984-09       Impact factor: 3.199

Review 8.  Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.

Authors:  S P Clissold; D M Campoli-Richards
Journal:  Drugs       Date:  1986-07       Impact factor: 9.546

9.  Omeprazole, a gastric 'proton pump inhibitor': lack of effect on renal handling of electrolytes and urinary acidification.

Authors:  C W Howden; J L Reid
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

10.  Comparative effects of adjuvant cimetidine and omeprazole during pancreatic enzyme replacement therapy.

Authors:  M J Bruno; E A Rauws; F J Hoek; G N Tytgat
Journal:  Dig Dis Sci       Date:  1994-05       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.